Archive for the ‘PanGenex Corp. PGCX’ Category

PanGenex Corp. (PGCX) Provides Investors with Overview of Certain Products

Wednesday, June 15th, 2011

PanGenex Corp., a nutraceutical and dietary supplement developer, today provided a differentiation of certain of its products that focus on soft tissue calcification.

OMEGANOL™ is the first dietary supplement to combine the health properties of concentrated Omega-3 with the antioxidant and cholesterol balancing properties of tocotrienols. By combining these essentials, Omeganol delivers double protection to the heart.

LIPIDEME™ promotes heart and cardiovascular health in four ways by combining the pure, concentrated, and medically proven ingredients Omega-3 fatty acids from fish oil, phytosterols, tocotrienols, and coenzyme Q10. When taken as directed, the ingredients in LIPIDEME have been demonstrated to reduce the risk of heart disease.

Let us hear your thoughts: PanGenex Corp. Message Board

PanGenex Corp. (PGCX) Provides Investor Update; Engages Phillips Sales & Marketing

Monday, June 13th, 2011

On Friday after the closing bell, PanGenex told investors that it is ready to launch a comprehensive marketing plan that will include a viral internet strategy, as well as engaging firms that have proven reach to retail outlets. The company has invested millions of dollars in developing its products which target soft tissue calcification.

Today that news was followed up by an announcement that reported PanGenex has engaged Philips Sales & Marketing, Inc. (PSM) as its agent to sell its products through mail order catalogs, small chain stores including independent health food stores and pharmacies as well as three of the nation’s largest drug store chains. PSM has also committed to providing marketing and advertising services for the company.

“We are excited to work with PSM because of their extensive experience in marketing and distributing nutraceutical products to the nation’s largest pharmacy retailers,” commented John Stanton, Chairman of PanGenex.

Brett Phillips, President of Phillips Sales & Marketing stated, “We are very impressed with PanGenex’s line of quality products and the professional staff they have assembled to supply our pipe line with cutting edge health products that should offer nutritional and health benefits to potentially millions of people not just in the U.S. but abroad as well.”

Let us hear your thoughts: PanGenex Corp. Message Board

PanGenex Corp. (PGCX) is “One to Watch”

Friday, June 10th, 2011

PanGenex Corp. is a nutraceutical and dietary supplement developer focused on pursuing business opportunities in the $70 billion nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, the company develops and markets sector-leading, patented or patent-pending, condition-specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products.

Many of the PanGenex’s products are available anywhere without a prescription. Primary products offered by the company include Calci-Clear, LIPIDEME and Omeganol, all of which address Soft Tissue Calcification (STC), an abnormal hardening or thickening of soft tissues (such as arteries). This condition is linked to over half of chronic diseases and currently affects an estimated 196 million Americans, or 60 percent of the U.S. population.

Since 2006, PanGenex has voluntarily submitted its product labels to the FDA without incidence. The company’s products are currently sold to healthcare practitioners in 20 U.S. states, Canada, Puerto Rico, Canada, Brazil, and Australia as well as online at www.HeartHealthyWorld.com.

Let us hear your thoughts: PanGenex Corp. Message Board